版本:
中国

BRIEF-Neurocrine announces proposed convertible senior notes offering

April 25 Neurocrine Biosciences Inc-

* Neurocrine announces proposed convertible senior notes offering

* Neurocrine Biosciences announces intent to offer $450 million of convertible senior notes due 2024 in a private offering Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐